Home/ Supplements/ Phosphorus/ Natural Soya Lecithin 300 mg

Natural Soya Lecithin 300 mg

product on market Softgel Capsule Solgar Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Lecithin and phosphorus provide essential components for cellular membrane integrity and cognitive function. Research indicates moderate evidence for lecithin's role in supporting lipid metabolism and brain health. Due to the low evidence coverage, the specific clinical impact of this formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Natural Soya Lecithin 300 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

6 Softgel(s)
Serving Size
16
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
35 mg (4% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
Lecithin
1800 mg

Other Ingredients

Gelatin Glycerin Water
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement for adults, take six (6) softgels daily, preferably at mealtime, or as directed by a healthcare practitioner.

Warnings & Precautions

Do not use if outer bottle seal is missing, torn or damaged in any way.

If you are pregnant, nursing, taking any medication or have a medical condition, please consult your healthcare practitioner before taking any dietary supplement.

Keep out of reach of children.

Formulation Notes

Solgar's Soya Lecithin Softgels are unbleached, free of corn, yeast, wheat and dairy products and are formulated without the use of preservatives, artificial flavors or colors.

Sugar, salt and starch free

Formulated for adults.

Natural Soya Lecithin 300 mg per softgel

Additional Information

To assure freshness and potency, store at room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F). Store away from heat, light and moisture.

Solgar since 1947

Metadata

Product Details

UPC / SKU0 33984 01520 3
DSLD Entry Date2020-02-26
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandSolgar
DSLD ID214601
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.